James Whims - 10 Nov 2021 Form 4 Insider Report for SYNAPTICS Inc (SYNA)

Role
Director
Signature
/s/ Kermit Nolan, as attorney-in-fact
Issuer symbol
SYNA
Transactions as of
10 Nov 2021
Net transactions value
-$1,344,055
Form type
4
Filing time
12 Nov 2021, 09:35:20 UTC
Previous filing
02 Nov 2021
Next filing
08 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYNA Common Stock Options Exercise $205,546 +2,302 +9.5% $89.29 26,651 10 Nov 2021 Direct
transaction SYNA Common Stock Sale $840,204 -3,377 -13% $248.80 23,274 10 Nov 2021 Direct F1
transaction SYNA Common Stock Sale $709,397 -2,839 -12% $249.88 20,435 10 Nov 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SYNA Director Stock Option (Right to Buy) Options Exercise $0 -2,302 -100% $0.000000* 0 10 Nov 2021 Common Stock 2,302 $89.29 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.12 to $249.11, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.32 to $250, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 One-twelfth of the total number of shares subject to the option vested and became exercisable on the 23rd day of each month following the October 23, 2015 date of grant, until fully vested on October 23, 2016.